Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 8 May 2006. doi:10.1136/gut.2005.083063
Gut 2006;55:1598-1605
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v55,p1824)
Right arrow All Versions of this Article:
gut.2005.083063v1
55/11/1598    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J
Right arrow Articles by Hoon, D S B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J
Right arrow Articles by Hoon, D S B
Topic Collections
Right arrowRelated Article

PANCREAS

Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins

J Kim1, H A Reber2, S M Dry3, D Elashoff4, S L Chen5, N Umetani6, M Kitago6, O J Hines2, K K Kazanjian2, S Hiramatsu6, A J Bilchik5, S Yong7, M Shoup8, D S B Hoon6

1 Department of Molecular Oncology and Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
2 Department of Surgery, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA
3 Department of Pathology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA
4 Department of Biostatistics, University of California-Los Angeles, Los Angeles, California, USA
5 Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
6 Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
7 Department of Pathology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
8 Department of Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA

Correspondence to:
Correspondence to:
Dr D S B Hoon
Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA; hoon{at}jwci.org

Background: Despite intent to cure surgery with negative resection margins, locoregional recurrence is common in pancreatic cancer.

Aims: To determine whether detection of K-ras gene mutation in the histologically negative surgical margins of pancreatic cancer reflects unrecognised disease.

Patients: Seventy patients who underwent curative resection for pancreatic ductal adenocarcinoma were evaluated.

Methods: All patients had surgical resection margins (pancreatic transection and retroperitoneal) that were histologically free of invasive cancer. DNA was extracted from these paraffin embedded surgical margins and assessed by quantitative real time polymerase chain reaction to detect the K-ras gene mutation at codon 12. Detection of K-ras mutation was correlated with standard clinicopathological factors.

Results: K-ras mutation was detected in histologically negative surgical margins of 37 of 70 (53%) patients. A significant difference in overall survival was demonstrated between patients with margins that were K-ras mutation positive compared with negative (median 15 v 55 months, respectively; p = 0.0008). By univariate and multivariate analyses, detection of K-ras mutation in the margins was a significant prognostic factor for poor survival (hazard ratio (HR) 2.8 (95% confidence interval (CI) 1.5–5.3), p = 0.0009; and HR 2.8 (95% CI 1.4–5.5), p = 0.004, respectively).

Conclusions: Detection of cells harbouring K-ras mutation in histologically negative surgical margins of pancreatic cancer may represent unrecognised disease and correlates with poor disease outcome. The study demonstrates that molecular-genetic evaluation of surgical resection margins can improve pathological staging and prognostic evaluation of patients with pancreatic ductal adenocarcinoma.


Abbreviations: JWCI, John Wayne Cancer Institute; H&E, haematoxylin and eosin; PanIN, pancreatic intraepithelial neoplasia; IHC, immunohistochemistry; PNA, peptide nucleic acid; PCR, polymerase chain reaction; wt, wild-type; HR, hazard ratio

Keywords: K-ras; pancreatic cancer; surgical margin; quantitative polymerase chain reaction


Related Article

An unfavourable prognosis for pancreatic cancer indicates fields of opportunity
W Greenhalf
Gut 2006 55: 1533-1535. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
GutHome page
W Greenhalf
An unfavourable prognosis for pancreatic cancer indicates fields of opportunity.
Gut, November 1, 2006; 55(11): 1533 - 1535.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology